Proposal for bail-out procedures - Cardiac general heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis

Interactive Cardiovascular and Thoracic Surgery

Volumn 8, Issue 4, 2009, Pages 439-441

  Kramer, Robert ^a   Oberg Higgins, Payson ^a   Russo, Louis ^a   Braxton, John H ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

Blood platelets; Hematology; Immunochemistry; Thrombosis

Indexed keywords

ALBUMIN; FRESH FROZEN PLASMA; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; HIRULOG; ANTIBODY; ANTICOAGULANT AGENT;

ADULT; ANAMNESIS; AORTA BALLOON; BLEEDING; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; CONVALESCENCE; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPOKINESIA; IMMUNOGLOBULIN G DEFICIENCY; LABORATORY TEST; MALE; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; MIDDLE AGED; SYNDROME; TREATMENT OUTCOME;

ANTIBODIES; ANTICOAGULANTS; CORONARY ARTERY BYPASS; HEART-ASSIST DEVICES; HEPARIN; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; SYNDROME; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME;

EID: 65249167550     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.193177     Document Type: Conference Paper

References (8)

1. Warkentin TE. Heparin-induced thrombocytopenia; pathogenesis and management. Br J Haematol 2003;121:535-555.
2. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003;76:638-648.
3. Linenberger ML, Price TH. Use of cellular and plasma apheresis in the critically ill patient: part II: clinical indications and applications. J Intensive Care Med 2005;20:88-103.
4. Robinson JA, Lewis BE. Plasmapheresis in the management of heparininduced thrombocytopenia. Semin Hematol 1999;36(Suppl 1):29-32.
5. Antonijevic NM, Savic NB, Perunicic J, Kovac M, Mikovic D, Stanojevic M, Calija B, Milosevic RA, Obradovic SD, Vasiljevic Z. Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia resistant to danaparoid sodium and lepirudin. J Clin Apheresis 2006;21:252-255.
6. Poullin P, Pietri PE, LefÈvre P. Heparin-induced thrombocytopenia with thrombosis: successful treatment with plasma exchange. Br J Haematol 1998;102:629-630.
7. Vender JS, Matthew EB, Silverman IM, Konowitz H, Dau PC. Heparinassociated thrombocytopenia: alternative managements. Anesth Analg 1986;65:520-522.
8. Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D. Presence of autoantibodies for interleukin-8 or neutrophil activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 1996;88:410-416.